Annual Working Capital
$33.20 M
+$10.50 M+46.29%
December 31, 2022
Summary
- As of February 10, 2025, PHXM annual working capital is $33.20 million, with the most recent change of +$10.50 million (+46.29%) on December 31, 2022.
- During the last 3 years, PHXM annual working capital has fallen by -$35.92 million (-51.97%).
Performance
PHXM Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
N/A
September 30, 2023
Summary
- PHXM quarterly working capital is not available.
Performance
PHXM Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
PHXM Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.3% | - |
| 3 y3 years | -52.0% | - |
| 5 y5 years | -84.6% | - |
PHXM Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -31.6% | ||
| 5 y | 5-year | -52.0% | -31.6% | ||
| alltime | all time | -84.6% | -93.4% |
PHAXIAM Therapeutics SA Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $14.71 M(-55.7%) |
| Dec 2022 | $33.20 M(+46.3%) | $33.20 M(-8.0%) |
| Jun 2022 | - | $36.10 M(+59.1%) |
| Dec 2021 | $22.69 M(-9.0%) | $22.69 M(-39.7%) |
| Jun 2021 | - | $37.62 M(+50.8%) |
| Dec 2020 | $24.95 M(-63.9%) | $24.95 M(-29.4%) |
| Jun 2020 | - | $35.33 M(-48.9%) |
| Dec 2019 | - | $69.12 M(-19.0%) |
| Dec 2019 | $69.12 M(-53.3%) | - |
| Sep 2019 | - | $85.30 M(-18.1%) |
| Jun 2019 | - | $104.20 M(-29.5%) |
| Dec 2018 | - | $147.86 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $147.86 M(-31.5%) | - |
| Jun 2018 | - | $185.60 M(-14.0%) |
| Dec 2017 | $215.90 M(+464.4%) | $215.90 M(+116.0%) |
| Jun 2017 | - | $99.94 M(+161.3%) |
| Dec 2016 | $38.25 M(-24.4%) | $38.25 M(-5.3%) |
| Jun 2016 | - | $40.39 M(-20.2%) |
| Dec 2015 | $50.63 M(+18.1%) | $50.63 M(+50.7%) |
| Jun 2015 | - | $33.60 M(-21.7%) |
| Dec 2014 | $42.89 M(+129.6%) | $42.89 M(+185.8%) |
| Jun 2014 | - | $15.00 M(-19.7%) |
| Dec 2013 | $18.68 M(+749.7%) | $18.68 M(-15.9%) |
| Jun 2013 | - | $22.20 M(+910.1%) |
| Dec 2012 | $2.20 M | $2.20 M |
FAQ
- What is PHAXIAM Therapeutics SA annual working capital?
- What is the all time high annual working capital for PHAXIAM Therapeutics SA?
- What is PHAXIAM Therapeutics SA annual working capital year-on-year change?
- What is the all time high quarterly working capital for PHAXIAM Therapeutics SA?
What is PHAXIAM Therapeutics SA annual working capital?
The current annual working capital of PHXM is $33.20 M
What is the all time high annual working capital for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high annual working capital is $215.90 M
What is PHAXIAM Therapeutics SA annual working capital year-on-year change?
Over the past year, PHXM annual working capital has changed by +$10.50 M (+46.29%)
What is the all time high quarterly working capital for PHAXIAM Therapeutics SA?
PHAXIAM Therapeutics SA all-time high quarterly working capital is $215.90 M